$BTCS
BTCS Inc. Stock $btcs

$btcs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010331 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$311.5K	$270.9K	$1.692M
YoY Change	-44.67%	-38.0%	39.49%
Cost Of Revenue	$82.01K	$112.5K	$426.4K
YoY Change	-40.51%	-8.12%	58.91%
Gross Profit	$229.5K	$158.4K	$1.266M
YoY Change	-46.02%	-49.62%	33.98%
Gross Profit Margin	73.67%	58.48%	74.8%
Selling, General & Admin	$616.1K	$906.7K	$1.994M
YoY Change	-70.88%	-62.31%	-88.51%
% of Gross Profit	268.45%	572.36%	157.53%
Research & Development	$201.6K	$163.2K	$611.8K
YoY Change	47.47%	47.59%	-14.17%
% of Gross Profit	87.86%	103.0%	48.32%
Depreciation & Amortization	$1.153K	$1.180K	$4.039K
YoY Change	44.13%	136.0%	329.68%
% of Gross Profit	0.5%	0.74%	0.32%
Operating Expenses	$1.358M	$1.070M	$18.76M
YoY Change	-39.72%	-57.48%	3.85%
Operating Profit	-$1.128M	-$911.5K	-$17.50M
YoY Change	-38.26%	-58.6%	2.18%
Interest Expense	-$268.2K	$515.8K	$2.146M
YoY Change	-52.96%	-69.42%	-56.38%
% of Operating Profit
Other Income/Expense, Net	-$285.0K	$0.00	$1.603M
YoY Change	699.89%	-100.0%	-13.99%
Pretax Income	-$1.413M	-$1.397M	-$15.89M
YoY Change	-75.38%	139.63%	-0.98%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$1.413M	-$1.397M	-$15.89M
YoY Change	-75.38%	139.63%	-0.98%
Net Earnings / Revenue	-453.72%	-515.73%	-939.04%
Basic Earnings Per Share	-$0.10		-$1.25
Diluted Earnings Per Share	-$0.10	-$0.11	-$1.25
COMMON SHARES
Basic Shares Outstanding	13.77M shares	13.08M shares	12.73M shares
Diluted Shares Outstanding	17.19M shares		12.73M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.543M	$2.247M	$2.247M
YoY Change	-68.27%	-50.27%	-50.27%
Cash & Equivalents	$1.400M	$2.100M
Short-Term Investments	$100.0K	$100.0K	$100.0K
Other Short-Term Assets	$7.949M	$1.951M	$1.951M
YoY Change	14.92%	105.74%	105.74%
Inventory
Prepaid Expenses	$93.45K	$123.7K
Receivables
Other Receivables
Total Short-Term Assets	$9.492M	$4.198M	$4.198M
YoY Change	-19.42%	-23.21%	-23.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.999K	$11.15K	$11.15K
YoY Change	-13.35%	13.99%	14.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$5.709M	$5.709M
YoY Change	-100.0%	-33.82%	-33.82%
Total Long-Term Assets	$9.999K	$5.720M	$5.720M
YoY Change	-99.89%	-33.76%	-33.76%
TOTAL ASSETS
Total Short-Term Assets	$9.492M	$4.198M	$4.198M
Total Long-Term Assets	$9.999K	$5.720M	$5.720M
Total Assets	$9.502M	$9.918M	$9.918M
YoY Change	-53.59%	-29.67%	-29.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$41.95K	$76.73K	$76.73K
YoY Change	-59.03%	-44.69%	-44.69%
Accrued Expenses	$45.38K	$372.7K	$295.9K
YoY Change	1313.8%	155.16%	3937.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$544.1K	$586.4K	$586.4K
YoY Change	-81.52%	-70.66%	-70.66%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$544.1K	$586.4K	$586.4K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$544.1K	$586.4K	$586.4K
YoY Change	-81.52%	-70.66%	-70.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$152.9M	-$151.5M
YoY Change		11.72%
Common Stock	$161.9M	$160.8M
YoY Change		8.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.958M	$9.331M	$9.331M
YoY Change
Total Liabilities & Shareholders Equity	$9.502M	$9.918M	$9.918M
YoY Change	-53.59%	-29.67%	-29.67%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.413M	-$1.397M	-$15.89M
YoY Change	-75.38%	139.63%	-0.98%
Depreciation, Depletion And Amortization	$1.153K	$1.180K	$4.039K
YoY Change	44.13%	136.0%	329.68%
Cash From Operating Activities	-$1.126M	-$647.3K	-$776.8K
YoY Change	6.71%	-32.38%	-84.02%
INVESTING ACTIVITIES
Capital Expenditures		$179.0K	$5.408K
YoY Change		-3107.9%	-100.06%
Acquisitions
YoY Change
Other Investing Activities	$47.54K	$52.88K	$485.6K
YoY Change	-84.67%
Cash From Investing Activities	-$86.48K	-$126.1K	-$8.973M
YoY Change	-98.95%	2019.16%	-5.28%
FINANCING ACTIVITIES
Cash Dividend Paid	$0.00		$631.0K
YoY Change	-100.0%
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$508.8K	31.20K	$10.50M
YoY Change	-94.97%	-98.17%	-31.0%
NET CHANGE
Cash From Operating Activities	-$1.126M	-647.3K	-$776.8K
Cash From Investing Activities	-$86.48K	-126.1K	-$8.973M
Cash From Financing Activities	$508.8K	31.20K	$10.50M
Net Change In Cash	-$703.7K	-742.2K	$745.9K
YoY Change	-183.36%	-200.04%	-14.92%
FREE CASH FLOW
Cash From Operating Activities	-$1.126M	-$647.3K	-$776.8K
Capital Expenditures		$179.0K	$5.408K
Free Cash Flow	-$1.126M	-$826.3K	-$782.2K
YoY Change	-115.08%	-13.14%	-116.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001436229
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Investments Investments		usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders		usd
CY2022	BTCS	Dividends Related Amortizationof Beneficial DividendsRelatedAmortizationofBeneficial		usd
CY2022	BTCS	Dividends Related Recognitionof Downround DividendsRelatedRecognitionofDownround		usd
CY2021	BTCS	Conversion Of Series C One Convertible Preferred Stock ConversionOfSeriesCOneConvertiblePreferredStock		usd
CY2021	BTCS	Conversion Of Series C Two Convertible Preferred Stock ConversionOfSeriesCTwoConvertiblePreferredStock		usd
CY2021	BTCS	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature One AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureOne		usd
CY2021	BTCS	Deemed Dividends Related To Amortization Beneficial Conversion Series C Two Convertible Preferred Stock DeemedDividendsRelatedToAmortizationBeneficialConversionSeriesCTwoConvertiblePreferredStock		usd
CY2021	BTCS	Deemed Dividends Related To Amortization Of Beneficial Conversion Feature Of Series C Convertible Preferred Stock One DeemedDividendsRelatedToAmortizationOfBeneficialConversionFeatureOfSeriesCConvertiblePreferredStockOne		usd
CY2021	BTCS	Fractional Shares Adjusted For Reverse Split FractionalSharesAdjustedForReverseSplit		usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022	BTCS	Stockbased Compensation In Connection With Issuances Of Series C Two Convertible Preferred Stock StockbasedCompensationInConnectionWithIssuancesOfSeriesCTwoConvertiblePreferredStock		usd
CY2021	BTCS	Blockchain Network Fees BlockchainNetworkFees		usd
CY2022	BTCS	Purchase Of Nonproductive Crypto Assets PurchaseOfNonproductiveCryptoAssets		usd
CY2021	BTCS	Proceeds From Sale Of Crypto Assets ProceedsFromSaleOfCryptoAssets		usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	BTCS	Net Proceeds From Issuance Of Common Stock And Warrants For Cash NetProceedsFromIssuanceOfCommonStockAndWarrantsForCash		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022	BTCS	Deemed Dividends Related To Amortization Of Beneficial Conversion Feature Of Series C Two Convertible Preferred Stock DeemedDividendsRelatedToAmortizationOfBeneficialConversionFeatureOfSeriesCTwoConvertiblePreferredStock		usd
CY2022	BTCS	Deemed Dividends Related To Recognition Of Downround Adjustment To Conversion Amount For Series C Two Convertible Preferred Stock DeemedDividendsRelatedToRecognitionOfDownroundAdjustmentToConversionAmountForSeriesCTwoConvertiblePreferredStock		usd
CY2022	BTCS	Conversion Of Series C One Preferred Stock ConversionOfSeriesCOnePreferredStock		usd
CY2022	BTCS	Conversion Of Series C Two Preferred Stock ConversionOfSeriesCTwoPreferredStock		usd
CY2022	BTCS	Beneficial Conversion Feature Of Series C Two Convertible Preferred Stock BeneficialConversionFeatureOfSeriesCTwoConvertiblePreferredStock		usd
CY2022	BTCS	Beneficial Conversion Features Associated With Convertible Notes Payable BeneficialConversionFeaturesAssociatedWithConvertibleNotesPayable		usd
CY2022	BTCS	Dividends Payable DividendsPayable		usd
CY2021	BTCS	Dividends Payable DividendsPayable		usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease		usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease		usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022	BTCS	Warrant Liabilities Classification WarrantLiabilitiesClassification		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40792
CY2022	dei	Entity Registrant Name EntityRegistrantName	BTCS Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1096644
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	9466 Georgia Avenue #124
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Silver Spring
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20910
CY2022	dei	City Area Code CityAreaCode	202
CY2022	dei	Local Phone Number LocalPhoneNumber	430-6576
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2022	dei	Trading Symbol TradingSymbol	BTCS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	12000000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13766321	shares
CY2022	dei	Auditor Firm AuditorFirmId	587
CY2022	dei	Auditor Name AuditorName	RBSM LLP
CY2022	dei	Auditor Location AuditorLocation	Las Vegas, Nevada
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2146783	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1400867	usd
CY2022Q4	BTCS	Crypto Assets CryptoAssets	982	usd
CY2021Q4	BTCS	Crypto Assets CryptoAssets	3117360	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	100000	usd
CY2022Q4	us-gaap	Investments Investments	100000	usd
CY2022Q4	BTCS	Staked Crypto Assets Current StakedCryptoAssetsCurrent	1826307	usd
CY2021Q4	BTCS	Staked Crypto Assets Current StakedCryptoAssetsCurrent	623754	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	123727	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	324551	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4197799	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	5466532	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11152	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9783	usd
CY2022Q4	BTCS	Staked Crypto Assets Noncurrent StakedCryptoAssetsNoncurrent	5708624	usd
CY2021Q4	BTCS	Staked Crypto Assets Noncurrent StakedCryptoAssetsNoncurrent	8625678	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5719776	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	8635461	usd
CY2022Q4	us-gaap	Assets Assets	9917575	usd
CY2021Q4	us-gaap	Assets Assets	14101993	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	76727	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	138716	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	295935	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7334	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1852500	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	586412	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1998550	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13107149	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13107149	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10528212	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10528212	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13108	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12732914	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10529	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	160800263	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	147682384	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151482208	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135589470	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9331163	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12103443	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9917575	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14101993	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1692454	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1213284	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	426440	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	268346	usd
CY2022	us-gaap	Gross Profit GrossProfit	1266014	usd
CY2021	us-gaap	Gross Profit GrossProfit	944938	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1916193	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1590707	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	611758	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	712736	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	3313638	usd
CY2021	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	15583258	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	78171	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	180290	usd
CY2022	BTCS	Impairment Loss On Crypto Assets ImpairmentLossOnCryptoAssets	13348874	usd
CY2021	BTCS	Impairment Loss On Crypto Assets ImpairmentLossOnCryptoAssets	3845899	usd
CY2022	BTCS	Realized Gains On Crypto Asset Transactions RealizedGainsOnCryptoAssetTransactions	506757	usd
CY2021	BTCS	Realized Gains On Crypto Asset Transactions RealizedGainsOnCryptoAssetTransactions	3054418	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	18761877	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	18858472	usd
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	186740	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1868059	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1638750	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3918750	usd
CY2022	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders	35625	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1603125	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1863951	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15892738	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16049583	usd
CY2021	BTCS	Dividends Related Amortizationof Beneficial DividendsRelatedAmortizationofBeneficial	-45541	usd
CY2021	BTCS	Dividends Related Recognitionof Downround DividendsRelatedRecognitionofDownround	-5020883	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15892738	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21116007	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.25
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.09
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6840665	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1043287	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3014005	usd
CY2021	BTCS	Issuance Of Common Stock Net Of Offering Cost Atthemarket Offering IssuanceOfCommonStockNetOfOfferingCostAtthemarketOffering	2832152	usd
CY2021	BTCS	Issuance Of Common Stock And Warrants For Cash Net IssuanceOfCommonStockAndWarrantsForCashNet	8865000	usd
CY2021	BTCS	Warrant Liabilities Value Related To Issuance Of Common Stock WarrantLiabilitiesValueRelatedToIssuanceOfCommonStock	-5771250	usd
CY2021	BTCS	Issuance Of Series C Two Convertible Preferred Stock IssuanceOfSeriesCTwoConvertiblePreferredStock	1100000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1000000	usd
CY2021	BTCS	Warrant Exercise WarrantExercise	400000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	15490555	usd
CY2021	BTCS	Stockbased Compensation In Connection With Issuance Of Series C Two Convertible Preferred Stock StockbasedCompensationInConnectionWithIssuanceOfSeriesCTwoConvertiblePreferredStock	179277	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16049583	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12103443	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12103443	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12103443	usd
CY2022	BTCS	Issuance Of Common Stock Net Of Offering Cost Atthemarket Offering IssuanceOfCommonStockNetOfOfferingCostAtthemarketOffering	11126331	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2625270	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-631143	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15892738	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9331163	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9331163	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15892738	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16049583	usd
CY2022	us-gaap	Depreciation Depreciation	4039	usd
CY2021	us-gaap	Depreciation Depreciation	939	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1868059	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2625270	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	15490555	usd
CY2021	BTCS	Stockbased Compensation In Connection With Issuances Of Series C Two Convertible Preferred Stock StockbasedCompensationInConnectionWithIssuancesOfSeriesCTwoConvertiblePreferredStock	179277	usd
CY2022	BTCS	Validator Revenue ValidatorRevenue	1692454	usd
CY2021	BTCS	Validator Revenue ValidatorRevenue	1213284	usd
CY2022	BTCS	Blockchain Network Fees BlockchainNetworkFees	1321	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1638750	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3918750	usd
CY2021	BTCS	Purchase Of Nonproductive Crypto Assets PurchaseOfNonproductiveCryptoAssets	5761550	usd
CY2022	BTCS	Sale Of Nonproductive Crypto Assets SaleOfNonproductiveCryptoAssets	2547325	usd
CY2021	BTCS	Sale Of Nonproductive Crypto Assets SaleOfNonproductiveCryptoAssets	4274491	usd
CY2022	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	506757	usd
CY2021	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	3054418	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	13348874	usd
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	3845899	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-200824	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	292676	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-62332	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	112428	usd
CY2022	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	288601	usd
CY2021	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-343042	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-776777	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4861655	usd
CY2022	BTCS	Purchase Of Productive Crypto Assets For Validating PurchaseOfProductiveCryptoAssetsForValidating	9453024	usd
CY2021	BTCS	Purchase Of Productive Crypto Assets For Validating PurchaseOfProductiveCryptoAssetsForValidating	9462279	usd
CY2022	BTCS	Proceeds From Sale Of Crypto Assets ProceedsFromSaleOfCryptoAssets	585595	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	100000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5408	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10491	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8972837	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9472770	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	630801	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	400000	usd
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	1100000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	usd
CY2021	BTCS	Net Proceeds From Issuance Of Common Stock And Warrants For Cash NetProceedsFromIssuanceOfCommonStockAndWarrantsForCash	8865000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3014005	usd
CY2022	BTCS	Net Proceeds From Issuance Common Stock Atthemarket Offering NetProceedsFromIssuanceCommonStockAtthemarketOffering	-11126331	usd
CY2021	BTCS	Net Proceeds From Issuance Common Stock Atthemarket Offering NetProceedsFromIssuanceCommonStockAtthemarketOffering	-2832152	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10495530	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15211157	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	745916	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	876732	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1400867	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	524135	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2146783	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1400867	usd
CY2021	BTCS	Deemed Dividends Related To Amortization Of Beneficial Conversion Feature Of Series C Two Convertible Preferred Stock DeemedDividendsRelatedToAmortizationOfBeneficialConversionFeatureOfSeriesCTwoConvertiblePreferredStock	45541	usd
CY2021	BTCS	Deemed Dividends Related To Recognition Of Downround Adjustment To Conversion Amount For Series C Two Convertible Preferred Stock DeemedDividendsRelatedToRecognitionOfDownroundAdjustmentToConversionAmountForSeriesCTwoConvertiblePreferredStock	5020883	usd
CY2021	BTCS	Conversion Of Series C One Preferred Stock ConversionOfSeriesCOnePreferredStock	20	usd
CY2021	BTCS	Conversion Of Series C Two Preferred Stock ConversionOfSeriesCTwoPreferredStock	6216289	usd
CY2021	BTCS	Beneficial Conversion Feature Of Series C Two Convertible Preferred Stock BeneficialConversionFeatureOfSeriesCTwoConvertiblePreferredStock	-129412	usd
CY2021	BTCS	Beneficial Conversion Features Associated With Convertible Notes Payable BeneficialConversionFeaturesAssociatedWithConvertibleNotesPayable	1000000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z7iAatPhe2D6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zaXfAYFxfqVj">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z7FkLXgLw6yl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zcNEOlVClC83">Concentration of Cash</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at four financial institutions in checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of six months or less when purchased to be cash and cash equivalents. As of December 31, 2022 and 2021, the Company had approximately $<span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20221231_z0RVFk9tSjBb" title="Cash and cash equivalents">2.1</span> million and $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20211231_zHS8befoteY1" title="Cash and cash equivalents">1.4</span> million in cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231__srt--RangeAxis__srt--MaximumMember_zsPE7phxpeUe" title="Cash, FDIC insured amount">250,000</span>. As of December 31, 2022 and 2021, the Company had approximately $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_pn5n6_c20221231_zzSNM2mbnpd9" title="Cash, FDIC insured amount">1.7</span> million and $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_pn5n6_c20211231_zpoOjsNqKQ99" title="Cash, FDIC insured amount">0.9</span> million in excess of the FDIC insured limit, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2100000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1400000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1700000	usd
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	900000	usd
CY2022	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	13300000	usd
CY2021	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	3800000	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	500000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	3100000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zUCxCoZU1Ta3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zjBz7pArWsal">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	631000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	78000	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	180000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3653053	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2227157	shares
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	100000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1852500	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	100000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	100000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1852500	usd
CY2021	BTCS	Warrant Liabilities Classification WarrantLiabilitiesClassification	5771250	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1638750	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3918750	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1852500	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14500	shares
CY2021Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 Reverse Split
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber	480000	shares
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber	14000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber	21000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1235000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.14
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1488000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.51
CY2022	BTCS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Grants In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGrantsInPeriod	P1Y4M24D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	100000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.90
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	35000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.50
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1150000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.15
CY2022	BTCS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P3Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1135000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.16
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y3M18D
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	275000	shares
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2800000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1521296	shares
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	372662	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1920547	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	284000	usd
CY2021Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	284000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	19.39
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.037	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0132	pure
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	5600	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	29363	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.96
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1670569	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.28
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	109379	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.29
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1590553	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.39
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2791851	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15457472	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	250323	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	200000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	200000	shares
CY2021	BTCS	Issuance Of Warrants Pursuant To Registered Direct Offering IssuanceOfWarrantsPursuantToRegisteredDirectOffering	712500	shares
CY2021	BTCS	Fractional Shares Adjusted For Reverse Split Shares FractionalSharesAdjustedForReverseSplitShares	-29	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	962794	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	50294	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	912500	shares
CY2022Q4	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	278498	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	278498	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	295935	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	9178	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	76727	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	51191	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1860177	usd
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	45000	usd
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	39000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2100000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	2776943	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	2287780	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	360818	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	225794	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	209797	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3363555	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2497578	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3363555	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2497578	usd
CY2022	BTCS	Operating Loss Carryforwards Expiration Date1 OperatingLossCarryforwardsExpirationDate1	expire in 2034
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The 20-year carryforward period has been replaced with an indefinite carryforward period for these NOLs generated in tax years beginning after December 31, 2017 and future years
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	900000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0672	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.065	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.2772	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.275	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.000	pure

Files In Submission

Name	View Source	Status
form10-k_htm.xml	Edgar Link	completed
btcs-20221231_def.xml	Edgar Link	unprocessable
0001493152-23-010331-index-headers.html	Edgar Link	pending
0001493152-23-010331-index.html	Edgar Link	pending
0001493152-23-010331.txt	Edgar Link	pending
0001493152-23-010331-xbrl.zip	Edgar Link	pending
btcs-20221231.xsd	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
ex4-7.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
btcs-20221231_pre.xml	Edgar Link	unprocessable
btcs-20221231_lab.xml	Edgar Link	unprocessable
btcs-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BTCS
BTCS Inc. Stock $btcs

2023 Q1 Form 10-K Financial Statement

#000149315223010331 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS BTCS Inc. Stock $btcs

2023 Q1 Form 10-K Financial Statement

#000149315223010331 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS
BTCS Inc. Stock $btcs